Lv5
1340 积分 2020-11-23 加入
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia
3天前
已完结
HH-GV-678, a novel selective inhibitor of Bcr-Abl, outperforms imatinib and effectively overrides imatinib resistance
11天前
已关闭
HH-GV-678, a novel selective inhibitor of Bcr-Abl, outperforms imatinib and effectively overrides imatinib resistance
11天前
已完结
Structure-based analysis and biological characterization of imatinib derivatives reveal insights towards the inhibition of wild-type BCR-ABL and its mutants
15天前
已完结
一代与二代酪氨酸激酶抑制剂联合化疗序贯异基因造血干细胞移植治疗Ph+急性淋巴细胞白血病疗效比较
17天前
已完结
Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions
18天前
已完结
儿童慢性髓细胞性白血病诊疗专家共识
22天前
已完结
Management of Philadelphia chromosome positive acute lymphoblastic leukemia in the current era
1个月前
已完结
Treatment of Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia—From Intensive Chemotherapy Combinations to Chemotherapy-Free Regimens
1个月前
已完结
Chronic myeloid leukaemia
1个月前
已完结
皖公网安备34019202002308
